Atezolizumab

SUSPENDED · PHASE2, PHASE3 · Extensive Stage Lung Small Cell Carcinoma

Scheduled Interim Monitoring

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.